Letrozole/ribociclib Interactions
There are 762 drugs known to interact with letrozole/ribociclib, along with 8 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 329 are major, 417 are moderate, and 16 are minor.
- View all 762 medications that may interact with letrozole/ribociclib
- View letrozole/ribociclib alcohol/food interactions (3)
- View letrozole/ribociclib disease interactions (8)
Most frequently checked interactions
View interaction reports for letrozole / ribociclib and the medicines listed below.
- Acidophilus Probiotic Blend (lactobacillus acidophilus)
- Aleve (naproxen)
- Allegra (fexofenadine)
- Ambien (zolpidem)
- Ativan (lorazepam)
- Bayer Women's Low Dose Plus Calcium (aspirin / calcium carbonate)
- Benadryl Allergy (diphenhydramine)
- Biotin Forte (multivitamin)
- Calcium 600 D (calcium / vitamin d)
- Caltrate 600+D Plus Minerals (multivitamin with minerals)
- Celexa (citalopram)
- Cetrotide (cetrorelix)
- Claritin (loratadine)
- Clomid (clomiphene)
- Compazine (prochlorperazine)
- Concerta (methylphenidate)
- CoQ10 (ubiquinone)
- Crestor (rosuvastatin)
- Cymbalta (duloxetine)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Glucosamine & Chondroitin with MSM (chondroitin / glucosamine / methylsulfonylmethane)
- Ibrance (palbociclib)
- Kisqali (ribociclib)
- Lipitor (atorvastatin)
- Super B Complex (multivitamin)
- Verzenio (abemaciclib)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zofran ODT (ondansetron)
Letrozole/ribociclib alcohol/food interactions
There are 3 alcohol/food interactions with letrozole / ribociclib.
Letrozole/ribociclib disease interactions
There are 8 disease interactions with letrozole / ribociclib which include:
- liver disease
- cholesterol
- osteoporosis
- cutaneous toxicity
- hepatic impairment
- lung toxicity
- QT prolongation
- renal impairment
More about letrozole / ribociclib
- letrozole/ribociclib consumer information
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antineoplastic combinations
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Arimidex
Arimidex is used to treat breast cancer in postmenopausal women. Learn about side effects ...
Femara
Femara lowers estrogen levels and is used to treat breast cancer in postmenopausal women. Learn ...
Herceptin
Herceptin is used to treat patients with metastatic breast cancer. Learn about side effects ...
Ibrance
Ibrance is used to treat HR-positive, HER2-negative breast cancer in postmenopausal women or men ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.